As of 2026-02-04, 云南金七制药的七叶神安滴丸's data on the DeepSeek platform in the 偏头痛急性治疗药物 category shows: The overall mention rate is 0.00%, above the industry average by 0.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
云南金七制药的七叶神安滴丸's Mention Rate is 0.00%, lower than 0.6% of competitors
云南金七制药的七叶神安滴丸's First Mention is 0.00%, lower than 0.9% of competitors
云南金七制药的七叶神安滴丸's Preferred Rate is 0.00%, lower than 100.0% of competitors
云南金七制药的七叶神安滴丸's Positive Rate is 0.00%, lower than 8.9% of competitors
云南金七制药的七叶神安滴丸's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 云云南金七制药的七叶神安滴丸 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
